Microcap Ledger Precipio, Inc. $PRPO
Facts as of . Built from SEC filings and our own data. Small caps move fast; check the latest filings.
Snapshot
- Exchange
- Nasdaq Capital Market
- Sector
- Laboratory Analytical Instruments
- Headquarters
- New Haven, CT
- Fiscal year end
- December 31
- Shares outstanding
- 1,790,188 [10-Q 2026-08-14]
What the company doesAI summary of filing
Precipio, Inc. is a healthcare biotechnology company that operates a clinical laboratory providing specialized cancer diagnostic testing services, primarily for hematologic malignancies, and develops proprietary diagnostic assays and kits for use by other clinical laboratories. The company generates revenue from its pathology services division, which operates two full laboratories conducting molecular diagnostics, cytogenetics, and related advanced laboratory analyses for healthcare providers, and from its products division, which develops and commercializes diagnostic assays designed for adoption by other laboratories. The company is revenue-generating, with approximately 40% of its revenue derived from government-sponsored healthcare programs in the year ended December 31, 2025, and operates an integrated model where clinical laboratory operations support research and development activities for new diagnostic products. [10-K 2026-03-30]
Financial health
| Period | Revenue | Net income | Operating cash flow | Cash | Filing |
|---|---|---|---|---|---|
| 6 months to Jun 2026 | $13.73M | −$1.66M | $724.0K | $3.08M | [10-Q 2026-08-14] |
| FY ended Dec 2025 | $24.05M | −$363.0K | $685.0K | $2.65M | [10-K 2026-03-30] |
| FY ended Dec 2024 | $18.53M | −$4.29M | $439.0K | $1.39M | [10-K 2026-03-30] |
Capital structure and dilution
| Date | Shares outstanding | Filing |
|---|---|---|
| 2024-11-03 | 1,482,333 | [10-Q 2024-11-06] |
| 2025-03-24 | 1,504,312 | [10-K 2025-03-27] |
| 2025-05-12 | 1,512,011 | [10-Q 2025-05-14] |
| 2025-08-10 | 1,619,584 | [10-Q 2025-08-13] |
| 2025-11-11 | 1,752,007 | [10-Q 2025-11-14] |
| 2026-03-23 | 1,783,682 | [10-K 2026-03-30] |
| 2026-05-11 | 1,787,372 | [10-Q 2026-05-14] |
| 2026-08-10 | 1,790,188 | [10-Q 2026-08-14] |
Listing status
Current status: No Form 8-K Item 3.01 (listing notice) filings in the last 24 months, as of 2026-10-11.
Who owns it
| Date | Insider | Type | Shares | Price | Filing |
|---|---|---|---|---|---|
| 2026-07-15 | Valauri Christina Rizopoulos | grant | 108 | $25.24 | [4 2026-07-16] |
| 2026-07-15 | Cossman Jeffrey | grant | 416 | $25.24 | [4 2026-07-16] |
| 2026-07-15 | Cohen David Seth | grant | 520 | $25.24 | [4 2026-07-16] |
| 2026-05-21 | Sandberg Richard A | sell | 900 | $25.02 | [4 2026-05-26] |
| 2026-05-20 | Sandberg Richard A | sell | 500 | $25.00 | [4 2026-05-21] |
| 2026-05-20 | Sandberg Richard A | sell | 2,034 | $24.89 | [4 2026-05-21] |
| 2026-05-19 | Sandberg Richard A | sell | 600 | $24.42 | [4 2026-05-21] |
| 2026-04-15 | Valauri Christina Rizopoulos | grant | 93 | $29.49 | [4 2026-04-17] |
| 2026-04-15 | Cossman Jeffrey | grant | 365 | $29.49 | [4 2026-04-17] |
| 2026-04-15 | Cohen David Seth | grant | 445 | $29.49 | [4 2026-04-17] |
Catalysts and calendar
| Date | Type | Title |
|---|---|---|
| 2026-08-14 | 8-K | Results of operations |
| 2026-08-14 | 10-Q | Quarterly report |
| 2026-07-31 | 8-K | Regulation FD disclosure |
| 2026-06-15 | 8-K | Shareholder vote results |
| 2026-05-14 | 10-Q | Quarterly report |
| 2026-05-06 | 8-K | Regulation FD disclosure |
| 2026-04-28 | DEF 14A | Proxy statement |
| 2026-03-30 | 10-K | Annual report |
| 2026-02-27 | 8-K | Results of operations |
| 2026-02-10 | 13G/A | Beneficial ownership report (5%+ holder) |
| 2025-12-29 | 8-K | Director or officer change |
| 2025-11-14 | 10-Q | Quarterly report |
Alerts for $PRPO
Email me when Precipio, Inc. files an offering, gets a deficiency notice, or moves sharply.
Facts as of . Small caps move fast; check the latest filings.